Digital Rehabilitation Program for Breast Cancer Survivors on Adjuvant Hormonal Therapy: A Feasibility Study

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2024 Dec 17

PMID 39682269

Authors

Wing-Lok Chan

Yat-Lam Wong

Yin-Ling Tai

Michelle Liu

Bryan Yun

YuNing Zhang

Holly Li-Yu Hou

Dora Kwong

Victor Ho-Fun Lee

Wendy Wing-Tak Lam

Affiliations

Soon will be listed here.

Abstract

: Breast cancer survivors often face physical and psychological challenges, including weight gain, metabolic syndrome, and reduced quality of life. To address these concerns, a mobile app-based rehabilitation program called "THRIVE" was developed to improve physical activity, medication adherence, and health-related quality of life (HRQoL) in this population. : This prospective, single-arm study assessed the feasibility and effectiveness of the "THRIVE" app among breast cancer survivors undergoing hormonal therapy. Participants were recruited from Queen Mary Hospital in Hong Kong between December 2022 and June 2023. Eligible survivors had completed treatment within the last five years or had stable advanced disease on hormonal therapy. Participants monitored their exercise, medication adherence, and self-care via the app and a Fitbit activity tracker for 16 weeks. Primary outcomes included recruitment, dropout, adherence rates, and safety. Secondary outcomes, measured at baseline and week 16, included physical activity intensity, HRQoL, psychological stress, body composition, and app satisfaction. : A total of 50 participants, with a median age of 53 years, completed the study. The recruitment rate was 70.4% with no dropouts. The adherence rate, measured by completing exercises recommended in the mobile app at least three times per week, was 74%. No severe adverse events were reported. While physical activity intensity showed no significant changes from baseline to week 16 ( = 0.24), cognitive function ( = 0.021), future perspective ( = 0.044), arm symptoms ( = 0.042), depression ( = 0.01), and anxiety ( = 0.004) improved. All participants reported perfect medication compliance (100%). Satisfaction with the app was high. : This mobile app-based rehabilitation program demonstrated good feasibility, with satisfactory recruitment, adherence, and safety, providing valuable insights into future definitive studies.

References

Leung C, Wing Y, Kwong P, Lo A, Shum K . Validation of the Chinese-Cantonese version of the hospital anxiety and depression scale and comparison with the Hamilton Rating Scale of Depression. Acta Psychiatr Scand. 2000; 100(6):456-61. DOI: 10.1111/j.1600-0447.1999.tb10897.x. View

Acheampong T, Kehm R, Terry M, Argov E, Tehranifar P . Incidence Trends of Breast Cancer Molecular Subtypes by Age and Race/Ethnicity in the US From 2010 to 2016. JAMA Netw Open. 2020; 3(8):e2013226. PMC: 7431997. DOI: 10.1001/jamanetworkopen.2020.13226. View

Lahart I, Metsios G, Nevill A, Carmichael A . Physical activity for women with breast cancer after adjuvant therapy. Cochrane Database Syst Rev. 2018; 1:CD011292. PMC: 6491330. DOI: 10.1002/14651858.CD011292.pub2. View

Vergani L, Marton G, Pizzoli S, Monzani D, Mazzocco K, Pravettoni G . Training Cognitive Functions Using Mobile Apps in Breast Cancer Patients: Systematic Review. JMIR Mhealth Uhealth. 2019; 7(3):e10855. PMC: 6444278. DOI: 10.2196/10855. View

Aaronson N, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez N . The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85(5):365-76. DOI: 10.1093/jnci/85.5.365. View

Juvet L, Thune I, Elvsaas I, Fors E, Lundgren S, Bertheussen G . The effect of exercise on fatigue and physical functioning in breast cancer patients during and after treatment and at 6 months follow-up: A meta-analysis. Breast. 2017; 33:166-177. DOI: 10.1016/j.breast.2017.04.003. View

Craig C, Marshall A, Sjostrom M, Bauman A, Booth M, Ainsworth B . International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003; 35(8):1381-95. DOI: 10.1249/01.MSS.0000078924.61453.FB. View

Pasanisi P, Berrino F, De Petris M, Venturelli E, Mastroianni A, Panico S . Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer. 2006; 119(1):236-8. DOI: 10.1002/ijc.21812. View

Melin J, Bonn S, Pendrill L, Trolle Lagerros Y . A Questionnaire for Assessing User Satisfaction With Mobile Health Apps: Development Using Rasch Measurement Theory. JMIR Mhealth Uhealth. 2020; 8(5):e15909. PMC: 7284402. DOI: 10.2196/15909. View

10.

Sprangers M, Groenvold M, Arraras J, Franklin J, Te Velde A, Muller M . The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol. 1996; 14(10):2756-68. DOI: 10.1200/JCO.1996.14.10.2756. View

11.

Calip G, Malone K, Gralow J, Stergachis A, Hubbard R, Boudreau D . Metabolic syndrome and outcomes following early-stage breast cancer. Breast Cancer Res Treat. 2014; 148(2):363-77. PMC: 4236717. DOI: 10.1007/s10549-014-3157-6. View

12.

Runowicz C, Leach C, Henry N, Henry K, Mackey H, Cowens-Alvarado R . American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA Cancer J Clin. 2015; 66(1):43-73. DOI: 10.3322/caac.21319. View

13.

Schmidt J, Beckjord E, Bovbjerg D, Low C, Posluszny D, Lowery A . Prevalence of perceived cognitive dysfunction in survivors of a wide range of cancers: results from the 2010 LIVESTRONG survey. J Cancer Surviv. 2015; 10(2):302-11. PMC: 5772767. DOI: 10.1007/s11764-015-0476-5. View

14.

Palmiero P, Maiello M, Cecere A, Ciccone M . Metabolic syndrome and breast cancer: a dangerous association for postmenopausal women. Acta Biomed. 2021; 92(4):e2021177. PMC: 8477089. DOI: 10.23750/abm.v92i3.11335. View

15.

Lovelace D, McDaniel L, Golden D . Long-Term Effects of Breast Cancer Surgery, Treatment, and Survivor Care. J Midwifery Womens Health. 2019; 64(6):713-724. DOI: 10.1111/jmwh.13012. View

16.

Winters-Stone K, Dobek J, Bennett J, Nail L, Leo M, Schwartz A . The effect of resistance training on muscle strength and physical function in older, postmenopausal breast cancer survivors: a randomized controlled trial. J Cancer Surviv. 2011; 6(2):189-99. PMC: 3488606. DOI: 10.1007/s11764-011-0210-x. View

17.

Cardoso F, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rubio I . Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019; 30(10):1674. DOI: 10.1093/annonc/mdz189. View

18.

Teresi J, Yu X, Stewart A, Hays R . Guidelines for Designing and Evaluating Feasibility Pilot Studies. Med Care. 2021; 60(1):95-103. PMC: 8849521. DOI: 10.1097/MLR.0000000000001664. View

19.

Loibl S, Andre F, Bachelot T, Barrios C, Bergh J, Burstein H . Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023; 35(2):159-182. DOI: 10.1016/j.annonc.2023.11.016. View

20.

Zigmond A, SNAITH R . The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6):361-70. DOI: 10.1111/j.1600-0447.1983.tb09716.x. View